Tumor-specific transgene expression: an application for hepatocarcinoma gene therapy.
Paillard
F
F
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000633:toxicity; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000628:therapy*; D011401:Promoter Regions, Genetic; D000509:alpha-Fetoproteins / Q000235:genetics*
D007376:Interleukin-2; D000509:alpha-Fetoproteins